These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2783887)

  • 1. Factors influencing antibody-mediated cytotoxicity during the immunotherapy of Rauscher-virus-induced myeloid leukemic cells.
    Berends D; van der Kwast TH; de Both NJ; Mulder PG
    Cancer Immunol Immunother; 1989; 28(2):123-30. PubMed ID: 2783887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syngeneic monoclonal antibodies directed against Rauscher virus-induced myeloid leukemic cells: isolation and characterization.
    Berends D; Rhijnsburger EH; van Gaalen JL; van Houwelingen G; Zondervan PE; de Both NJ
    Int J Cancer; 1988 Jul; 42(1):112-8. PubMed ID: 2455690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The detection of virally induced tumors by 131I- and 125I-labeled syngeneic monoclonal antibodies.
    Berends D; van Gaalen JL; Rhijnsburger EH; de Both NJ; Breeman W; Bakker WH; Kooy P
    Cancer Immunol Immunother; 1988; 26(3):243-9. PubMed ID: 3164257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemic cell targeting and therapy by monoclonal antibody in a mouse model system.
    Scheinberg DA; Strand M
    Cancer Res; 1982 Jan; 42(1):44-9. PubMed ID: 6947860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to rauscher virus-induced leukemia in DBA mice. I. Role of cellular and humoral immunity in spontaneous regression.
    Tóth FD; Gomba S; Váczi L; Kása M; Jakó J
    Neoplasma; 1976; 23(5):471-81. PubMed ID: 980178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of syngeneic monoclonal antibodies in the therapy of disseminated myeloid leukemic cells.
    Berends D; Mulder AH; van Houwelingen G; de Both NJ
    Int J Cancer; 1988 Jul; 42(1):42-7. PubMed ID: 3164709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
    Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H
    Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antilymphocytic humoral autoimmune response of mice with developing Rauscher leukemia directed against group-specific retrovirus antigens].
    Ter-Grigorov VS; Graf IA; Pivnik AV; Etkin AF; Moskovkina OIa
    Eksp Onkol; 1987; 9(6):48-51. PubMed ID: 3325268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of anti-lymphocyte and anti-thymocyte serum on the pathogenesis of Rauscher leukaemia in inbred mouse strains.
    Váczi L; Leövey A; Tóth FD; Kása M
    Acta Microbiol Acad Sci Hung; 1976; 23(4):309-16. PubMed ID: 1088332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of leukemogenesis. I. Generation of autoreactive lymphocytes in response to a murine leukemia virus.
    Schenk PJ; Howe ML
    J Immunol; 1979 May; 122(5):1874-80. PubMed ID: 221580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accessory cells in the in vitro generation of type C virus-specific T killer lymphocytes. II. Demonstration of a T helper cell in the spleen of in vivo primed mice.
    Gomard E; Wybier-Franqui J; Simmler MC; McKenzie IF; Levy JP
    J Immunol; 1981 Dec; 127(6):2291-5. PubMed ID: 6170695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of antibody isotype on passive serotherapy of lymphoma.
    Denkers EY; Badger CC; Ledbetter JA; Bernstein ID
    J Immunol; 1985 Sep; 135(3):2183-6. PubMed ID: 2862210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies specific for the neu oncogene product directly mediate anti-tumor effects in vivo.
    Drebin JA; Link VC; Greene MI
    Oncogene; 1988 Apr; 2(4):387-94. PubMed ID: 2896329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effector cells of low-dose IL-2 immunotherapy in tumor bearing mice: tumor cell killing by CD8+ cytotoxic T lymphocytes and macrophages.
    Maas RA; Roest PA; Becker MJ; Weimar IS; Dullens HF; Den Otter W
    Immunobiology; 1992 Nov; 186(3-4):214-29. PubMed ID: 1490728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195.
    Tanimoto M; Scheinberg DA; Cordon-Cardo C; Huie D; Clarkson BD; Old LJ
    Leukemia; 1989 May; 3(5):339-48. PubMed ID: 2716349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of mouse leukemia with monoclonal antibodies directed against type-C virus structural proteins.
    Boiocchi M; Mondellini P
    Tumori; 1984 Feb; 70(1):9-16. PubMed ID: 6324432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
    Masui H; Moroyama T; Mendelsohn J
    Cancer Res; 1986 Nov; 46(11):5592-8. PubMed ID: 3756906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
    Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting C-type lectin-like molecule-1 for antibody-mediated immunotherapy in acute myeloid leukemia.
    Zhao X; Singh S; Pardoux C; Zhao J; Hsi ED; Abo A; Korver W
    Haematologica; 2010 Jan; 95(1):71-8. PubMed ID: 19648166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.